Distribution of Bamlanivimab/Etesevimab Paused in Several States
June 7, 2021 | Strategic Insights for Ambulatory Care
Preview
What's the news. Distribution of the monoclonal antibody combination of bamlanivimab and etesevimab, authorized for emergency use treatment of COVID-19, has been paused in multiple states where the spread of certain SARS-CoV-2 variants is high, the Assistant Secretary for Preparedness and Response (ASPR), U.S. Department of Health and Human Services, said in a May 26, 2021, announcement.